Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa.
The distinction between metastasis from a colorectal adenocarcinoma into the ovary and an ovarian adenocarcinoma is vital, but challenging at times, due to overlapping morphological features. Similarly, a distinction between an ovarian metastasis into the colorectum and a colorectal adenocarcinoma, although rare; is important and can be daunting. We report an analysis of 20 cases of ovarian involvement by metastatic colorectal adenocarcinomas and colorectal involvement by metastatic ovarian adenocarcinomas, including the value of differential expression of cytokeratins 7 & 20 by immunohistochemistry (IHC), in these cases. Nine cases (45%) were identified as colorectal adenocarcinomas metastatic to the ovary. On biopsy, all these cases showed a 'garland-like' tumor necrosis, with desmoplasia and predominantly exhibited a tubuloalveolar pattern (67% cases). On IHC, all 8 of 9 such cases, where staining for cytokeratin 20 was performed, displayed strong positivity and 7 cases, where staining for carcinoembryogenic antigen (CEA) was performed, revealed positivity for this marker (100%). Other 11 cases (55%) were ovarian adenocarcinomas, metastatic to the colorectum. These showed metachronous presentations, with the ovarian tumor preceding the colorectal tumor deposits. Morphologically, psammomatous calcification was noted in 73% of these cases, whereas 'garland-like' necrosis was absent in all. The chief morphological subtype was serous papillary cystadenocarcinoma (55% cases). On IHC, CK7 and CA 125 were positive in all 6 of 11 such cases, whereas CK 20 was negative in all these cases.In cases of complex presentations like an ovarian involvement by a metastatic colorectal adenocarcinoma and vice-versa, certain clinicopathological features are useful. Differential expression of CK 7 and CK20 is vital in resolving these dilemmas. CK20 positivity and CK7 negativity is associated with a colorectal adenocarcinoma. Markers like CEA and CA-125 have an added value.
Rekhi
Bharat
B
Department of Pathology, Tata Memorial Hospital, Mumbai, India. rekhi.bharat@gmail.com
George
Sophia
S
Madur
Bhulaxmi
B
Chinoy
R F
RF
Dikshit
Rajesh
R
Maheshwari
Amita
A
Dis Colon Rectum. 1998 Oct;41(10):1312-4; discussion 1314-5
9788396
Am J Clin Pathol. 2002 Jun;117(6):944-51
12047147
Gynecol Oncol. 2006 Apr;101(1):97-101
16278010
Cancer. 1989 Oct 1;64(7):1508-13
2776109
Hum Pathol. 2002 Nov;33(11):1078-85
12454811
Semin Diagn Pathol. 2005 Feb;22(1):3-32
16512597
Am J Surg Pathol. 2006 Feb;30(2):177-84
16434891
Gynecol Oncol. 1995 Nov;59(2):200-6
7590473
Am J Clin Pathol. 1992 Jun;97(6):751-8
1595595
Histopathology. 2005 Sep;47(3):231-47
16115224
Am J Pathol. 1990 Mar;136(3):641-55
1690512
Hum Pathol. 1998 May;29(5):491-7
9596273
Am J Pathol. 1992 Feb;140(2):427-47
1371204
J Clin Oncol. 1997 Jan;15(1):368-81
8996164
Jpn J Clin Oncol. 1997 Jun;27(3):193-6
9255277
Am J Surg Pathol. 1987 Feb;11(2):114-21
3812871
Gynecol Oncol. 2004 Sep;94(3):850-3
15350388
Am J Surg Pathol. 2006 Sep;30(9):1130-9
16931958